Discontinuing half-dose csDMARD feasible in some patients with RA in remissionApril 27, 2023Rheumatoid Arthritis
Patients with preexisting RA can safely initiate immune checkpoint inhibitors for cancerApril 27, 2023Rheumatoid Arthritis
Rheumatology NewsMeta-analysis examines cancer risk concern for JAK inhibitorsApril 26, 2023Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
Rheumatology NewsRegistry data ‘reassure’ on biologics’ heart attack risk in rheumatoid arthritisApril 25, 2023Rheumatoid Arthritis
Rheumatology NewsBiosimilars and patients: Discussions should address safety, cost, and anxiety about changeMarch 30, 2023Business of MedicineRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsLupus & Connective Tissue DiseasesAnkylosing spondylitis
Rheumatology NewsDMARDs taper-to-discontinuation trial deemed inconclusiveMarch 28, 2023Rheumatoid Arthritis
Rheumatology NewsFDA approves new formulation of Hyrimoz adalimumab biosimilarMarch 27, 2023Rheumatoid ArthritisPsoriatic ArthritisPediatricsAnkylosing spondylitisSpondyloarthropathies
Real-world study compares discontinuation rates of tofacitinib and TNFi in RAMarch 27, 2023Rheumatoid Arthritis
Systemic immune-inflammation index: Novel biomarker to predict RA risk in adultsMarch 27, 2023Rheumatoid Arthritis
Joint damage associated with increased disability but not pain in early RAMarch 27, 2023Rheumatoid Arthritis
Pretreatment calprotectin offers no additional variability beyond CRP in predicting response to TNFi in RAMarch 27, 2023Rheumatoid Arthritis
Real-world study: Predictors of long-term remission in rheumatoid arthritisMarch 27, 2023Rheumatoid Arthritis
Early menopause worsens disease outcomes in postmenopausal women with RAMarch 27, 2023Rheumatoid Arthritis
CT-based screening for malignancies may benefit patients with RA who initiated b/tsDMARDMarch 27, 2023Rheumatoid Arthritis
